Nitya G. Ray
Keine laufenden Positionen mehr
Vermögen: 55 544 $ am 31.05.2024
Profil
Nitya G.
Ray worked as a Director of Bioprocess Development at Forticell Bioscience, Inc. from 1997 to 2001.
He then worked at Progenics Pharmaceuticals, Inc. for 17 years, starting as a Senior Vice President of Manufacturing in 2001 and ending as an Executive Vice President in 2018.
In 2017, he briefly worked as an Executive Vice President at Actinium Pharmaceuticals, Inc. before becoming the Chief Technology Officer at CytoDyn, Inc. in 2018.
Dr. Ray received his undergraduate degree from Jadavpur University and his graduate and doctorate degrees from Rutgers State University of New Jersey.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CYTODYN INC.
0,04% | 11.09.2023 | 351 545 ( 0,04% ) | 55 544 $ | 31.05.2024 |
Ehemalige bekannte Positionen von Nitya G. Ray
| Unternehmen | Position | Ende |
|---|---|---|
| CYTODYN INC. | Geschäftsführer | 19.04.2022 |
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 21.12.2018 |
| PROGENICS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.10.2018 |
Forticell Bioscience, Inc.
 Forticell Bioscience, Inc. BiotechnologyHealth Technology Forticell Bioscience, Inc. focuses on advanced regenerative medicine and stem cell therapy. The company was founded in 1991 and is headquartered in Englewood Cliffs, NJ. | Corporate Officer/Principal | 01.01.2001 |
Ausbildung von Nitya G. Ray
| Rutgers State University of New Jersey | Doctorate Degree |
| Jadavpur University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| CYTODYN INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
Forticell Bioscience, Inc.
Forticell Bioscience, Inc. BiotechnologyHealth Technology Forticell Bioscience, Inc. focuses on advanced regenerative medicine and stem cell therapy. The company was founded in 1991 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
